Arcutis director Terrie Curran disposes of common shares worth $279,129.66
ARQT•Terrie Curran exercises options and sells shares
- Arcutis Biotherapeutics director Terrie Curran exercised stock options on Aug. 27, 2026, acquiring 38,200 common shares at USD 7.51–8.63.
- Curran sold 38,200 common shares the same day at a weighted average price of USD 25.03.
- Directly held common shares fell to 23,526 following the transactions.
